Indications for antiviral hepatitis B therapy according to Decision 5448/QĐ-BYT (n=183) Comment: The percentage of pregnant women with indications for treatment to prevent MTCT was 13.1%; The percentage of pregnant women with indications for CHB therapy was 4.9%.